COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation.
Lanting YangShangbin TangJingchuan GuoNico GabrielWalid F GelladUtibe R EssienJared W MagnaniInmaculada HernandezPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)
In a nationwide sample of patients with established AF, we found the relative increase in stroke risk associated with COVID-19 was independent of OAC use.